Evidence map›Paper›PMID 20636805›Full record

ReviewImmunological reviews2010

Programmed cell death of dendritic cells in immune regulation.

Min Chen, Jin Wang

Abstract readReview
In one paragraph

Review in Immunological reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Apolipoproteins L involvement in immunity.Journal of human immunity · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Dendritic cells resist to disulfiram-induced cytotoxicity, but reduced interleukin-12/23(p40) production.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Min ChenDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.
Jin Wang

Funding

Roles of Dendritic Cells in Immune RegulationR01AI074949 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI WANG, JIN · 2007 to 2011
$1.7M
Molecular Regulation of Erythroid DifferentiationR01DK083164 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI CHEN, MIN · 2009 to 2013
$1.5M
Activation and in vivo Functions of Initiator CaspasesR01GM087710 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI WANG, JIN · 2009 to 2012
$1.4M
NIAID NIH HHS R01 AI074949NIDDK NIH HHS R01 DK083164NIGMS NIH HHS R01 GM087710
6 · The paper itself

Abstract

Programmed cell death is essential for the maintenance of lymphocyte homeostasis and immune tolerance. Dendritic cells (DCs), the most efficient antigen-presenting cells, represent a small cell population in the immune system. However, DCs play major roles in the regulation of both innate and adaptive immune responses. Programmed cell death in DCs is essential for regulating DC homeostasis and consequently, the scope of immune responses. Interestingly, different DC subsets show varied turnover rates in vivo. The conventional DCs are relatively short-lived in most lymphoid organs, while plasmacytoid DCs are long-lived cells. Mitochondrion-dependent programmed cell death plays an important role in regulating spontaneous DC turnover. Antigen-specific T cells are also capable of killing DCs, thereby providing a mechanism for negative feedback regulation of immune responses. It has been shown that a surplus of DCs due to defects in programmed cell death leads to overactivation of lymphocytes and the onset of autoimmunity. Studying programmed cell death in DCs will shed light on the roles for DC turnover in the regulation of the duration and magnitude of immune responses in vivo and in the maintenance of immune tolerance.

Indexed as

Adaptive ImmunityAnimalsAntigen-Presenting CellsApoptosisCell CommunicationDendritic CellsHumansImmunity, InnateModels, ImmunologicalT-Lymphocytes

Identifiers

PMID20636805
PMCPMC3282617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.